Oramed Pharmaceuticals Inc. Share Price
NASDAQ: ORMP | Micro CapOramed Pharmaceuticals Inc. Stock Performance
Oramed Pharmaceuticals Inc. Share Price Today
As of 19 September 2026, Oramed Pharmaceuticals Inc.'s share price is $4.73. The stock opened at $4.66, compared to its previous close of $4.67. During today's trading session, Oramed Pharmaceuticals Inc.'s share price traded between $4.63 and $4.79, with an average price of $4.71. Over the past 52 weeks, the stock has recorded a high of $5.47 and a low of $2.09. In terms of performance, Oramed Pharmaceuticals Inc.'s share price has risen by 38.30% over the last six months and is up 79.85% on a year-on-year basis.
Oramed Pharmaceuticals Inc. Share Price Chart
Oramed Pharmaceuticals Inc. Quarterly Profit & Loss
All figures in USD
Oramed Pharmaceuticals Inc. Annual Profit & Loss
All figures in USD
About Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Oramed Pharmaceuticals Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $5.08 | $4.72 | -7.90% |
Aug 2026 | $4.15 | $5.13 | +25.77% |
Jul 2026 | $4.67 | $4.08 | -15.10% |
Jun 2026 | $3.98 | $4.80 | +20.30% |
May 2026 | $3.93 | $3.99 | +2.31% |
Apr 2026 | $3.42 | $3.90 | +14.04% |
Mar 2026 | $3.44 | $3.42 | +0.29% |
Feb 2026 | $3.29 | $3.41 | +1.19% |
Jan 2026 | $2.86 | $3.37 | +18.25% |
Dec 2025 | $2.76 | $2.85 | -0.35% |
Nov 2025 | $2.37 | $2.86 | +20.42% |
Oct 2025 | $2.61 | $2.38 | -9.70% |